Mei‐Zhen Cui
- Molecular Biology top 10%
- Physiology top 5%
- Immunology top 10%
- Cell Biology top 10%
- Surgery
- Topics
- Alzheimer's disease research and treatments (13 papers)Sphingolipid Metabolism and Signaling (8 papers)Protein Kinase Regulation and GTPase Signaling (7 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Mei‐Zhen Cui
54 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 1.1k
- Physiology 487
- Immunology 272
- Cell Biology 205
- Surgery 186
Countries citing papers authored by Mei‐Zhen Cui
This map shows the geographic impact of Mei‐Zhen Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Zhen Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Zhen Cui more than expected).
Fields of papers citing papers by Mei‐Zhen Cui
This network shows the impact of papers produced by Mei‐Zhen Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Zhen Cui. The network helps show where Mei‐Zhen Cui may publish in the future.
Co-authorship network of co-authors of Mei‐Zhen Cui
This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Zhen Cui. A scholar is included among the top collaborators of Mei‐Zhen Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Zhen Cui. Mei‐Zhen Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 9 | |
| 5 | 26 | |
| 6 | 9 | |
| 7 | 29 | |
| 8 | 10 | |
| 9 | 20 | |
| 10 | 33 | |
| 11 | 37 | |
| 12 | 32 | |
| 13 | 18 | |
| 14 | 77 | |
| 15 | 118 | |
| 16 | 50 | |
| 17 | 46 | |
| 18 | 20 | |
| 19 | 64 | |
| 20 | 35 |
About Mei‐Zhen Cui
Mei‐Zhen Cui is a scholar working on Immunology and Allergy, Hematology and Immunology, having authored 54 papers that have together received 1.8k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (13 papers), Sphingolipid Metabolism and Signaling (8 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). The work is most often cited by research in Physiology (487 citations), Molecular Biology (1.1k citations) and Hematology (173 citations). Mei‐Zhen Cui has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Xuemin Xu, Guozhang Mao, Yunzhou Dong, Guy Chisolm, Mingqi Tan, Hao Feng, Jianxin Tan, Guojun Zhao, Marc S. Penn and Nigel Mackman. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.